SLU-PP (whether 332 or 915) are not peptides but rather small molecule experimental drugs. Discussing them in the “peptides” thread only serves to perpetuate this misunderstanding.
I appreciate you bringing it up.
Even though SLU-PP-332 is NOT a peptide, it is commonly categorized as such and almost 99% of people that would dabble in ERR would be peptide users.
Thus, I believe it to be a valuable addition to this thread I started way back when.
Please continue to share any research you are doing with SLU-PP-332 etc and any results, affects etc.
It’s interesting that they are suing companies that apparently no one has heard of. Not sure what their strategy is, but it may in part depend on vendors who are careless in advertising and careless in their dealings with customers (providing email evidence for instance that they know customers are self-injecting the product, giving them customer support helping them do this, etc).
From its responses, perplexity seems to be assuming your question is directed at nerve injury from trauma rather than aging. I’d consider re-asking the question and specify nerve degeneration from the aging process.
I thought it was interesting, and brilliant, that Brian Johnson has gone all in on online healthcare.
Most of us have much less expensive sourcing for peptides, but for someone who had no other options and wanted to pay with a credit card, I’d trust his product. He’s also offering other rx’s. Genius!